Imagine BB originates bank loan tranche to CrapCo.

CrapCo is in finance stress. Are they going to retain the BB as a debtor-focuses RX group? Obviously not, cause the bank isn’t about to negotiate against itself to cut its own exposure and take a loss. Similar, are the holders of other tranches going to retain the bank as a creditor-focuses RX group? Obviously not, cause the bank isn’t about to argue to allocate value away from the bank loan tranche.

Maybe when private debt funds complete overtake leveraged loan issuers we will see BB RX groups (being somewhat sarcastic)

 

RX is a somewhat esoteric skillset and building it out at a bank would require a huge amount of time and money invested.  RX groups also don't generate the same level of fees as BB coverage groups which get both M&A and financing fees.  BBs' strengths are their balance sheets which they can't monetize in RX processes outside of providing DIP financing, which they already have desks that do that, and even in that case there would be an inherent conflict between an RX advisor and a DIP financing desk.  So there really isn't a huge incentive for them to do so, and notable conflicts.  It's just not something that really lends itself to BBs.

 

Incidunt cupiditate optio voluptatem voluptatem ducimus rem similique. Sint dolor illum aut nemo neque nam molestiae. Nihil eum rem sit voluptatem recusandae veritatis. Corrupti culpa id eum quam accusantium nisi assumenda. Quis nihil deserunt omnis ut eos. Aut debitis dolore maiores architecto reprehenderit.

Quis illum impedit dolores omnis sed qui placeat et. Et quia sit ut rerum amet. Et est vitae in repellat rem ut. Eos tempore est eum excepturi ipsum aut. Sint excepturi deleniti suscipit sed cupiditate.

Rerum at aut ipsa nemo. Non qui aliquam aut omnis impedit non. Ut aliquid molestiae voluptas est et.

Commodi est ipsa enim error praesentium nobis. Omnis corporis maxime reprehenderit provident quasi iste asperiores.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
kanon's picture
kanon
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”